Zoe Sayre Walls, MS CFY-SLP | |
3 Brazier Ln, Kennebunk, ME 04043-6938 | |
(207) 985-3030 | |
Not Available |
Full Name | Zoe Sayre Walls |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 3 Brazier Ln, Kennebunk, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1598416257 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | ST3649 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Zoe Sayre Walls, MS CFY-SLP 107 Alfred Rd, Kennebunk, ME 04043-6182 Ph: (973) 727-0403 | Zoe Sayre Walls, MS CFY-SLP 3 Brazier Ln, Kennebunk, ME 04043-6938 Ph: (207) 985-3030 |
News Archive
b3 bio inc. today announced that it has signed an agreement with Roche to source and develop innovative early stage technologies that could result in potential therapeutic benefits for patients. Roche will have certain rights for further development and/or commercialization of such technologies. As part of this agreement, Roche will increase its equity investment in b3 bio as well as providing development funds.
A special issue of Journal of Ocular Pharmacology and Therapeutics highlights the latest research on matricellular proteins, which play a critical role in inflammation and blood vessel formation in the eye and therefore making them key targets for new therapies to treat common ocular disorders such as glaucoma, dry eye disease, and age-related macular degeneration (AMD).
In a study published in Pediatric Obesity, a child's high and increasing body mass index between ages two and six years was strongly associated with pre-pregnancy obesity and overweight in the child's mother; modestly associated with maternal type 1 diabetes, type 2 diabetes, gestational diabetes that required medication, and excessive weight gain during pregnancy; and slightly associated with breastfeeding for six months or less.
Researchers from University College London have won a £25,000 prize for developing technology that could be used to improve medical imaging, the targeted delivery of drugs and much more.
A new study published in the current issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) suggests that the biologic agent adalimumab may be a viable treatment option for patients with steroid-resistant refractory pediatric uveitis.
› Verified 2 days ago
Alla Johnson, SLP/CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3 Brazier Ln, Kennebunk, ME 04043 Phone: 207-985-3030 | |
Ms. Johanna Lee Gilland, MACCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 79 Cat Mousam Rd, Kennebunk, ME 04043 Phone: 207-985-3030 | |
Ellen Elizabeth Stone Benson, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 79 Cat Mousam Rd, Kennebunk, ME 04043 Phone: 207-985-3030 | |
Mrs. Megan Elise Jackins, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 89 Fletcher St, Kennebunk, ME 04043 Phone: 207-985-1110 | |
Penelope Pollard, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3 Brazier Ln, Kennebunk, ME 04043 Phone: 207-985-3030 | |
Mrs. Molly Camp Joyce, MS-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 158 Ross Rd, Kennebunk, ME 04043 Phone: 207-604-7115 | |
Saco Bay Orthopaedic And Sports Physical Therapy, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 65 Portland Rd Unit B, Kennebunk, ME 04043 Phone: 207-849-5041 |